After the announcement of US President Donald Trump, there was a major decline in shares of Indian pharmaceutical companies, in which he said that he was going to sign an order that reduced the prices of American drugs by about 30 to 80 per cent. After this, the shares of the country’s big pharmaceutical company Sun Pharma fell to 1,623.60 in early trade by Monday i.e. May 12.

Along with this, shares of pharmaceutical companies like Astrazenica, Lupine, Glenmark and Arabido Pharma also saw a decline of 3 percent. & Nbsp;

Trump wrote on his social media platform Truth Social- For many years, the world is surprised by these things why the drugs of other countries in America are so high. Some medicines are five to ten times more expensive, while the same laboratory or plant has been prepared by the same company.

Pharma shares fell from Trump’s announcement

Trump accused the pharmaceutical companies of discrimination on research and development expenses, saying that American consumers were put unnecessary burden for unnecessary years.

Similarly, shares of pharma companies saw a decline in the entire Asian market. Shares of drug manufacturers from South Korea and Japan were also seen slipping. During the Tokyo Trade, the pharmaceutical pharmaceutical pharmaceutical has come down by 7.2 percent, which is the fastest decline in this month.

Whereas, shares of Daiichi Sankyo and Takeda pharmaceutical companies fell down by 5 percent. South Korea’s SK Biofarmasuticals, CellTrion and Samsung Biologics shares also saw a decline of 3 per cent. The special thing here is that this was the President trumped to bring a policy in 2020 even during its previous tenure. But, his move was stayed by the court.

Source link

The post Shares of pharma companies collapsed by the announcement of President Trump, 7 percent break in Sun Pharma appeared first on .

Tata consumer products share prices were seen in early trade on Wednesday after upgrading the stocks of stocks from Global brokerage firm Goldmen Sachs and raising its price. The shares of Tata Consumer Products climbed 8.15% to Rs 1073.15 per share in NSE Infrade.

Brokerage firm Kotter Security said in a report released on April 1 that the fourth quarter results of the companies will play an important role in deciding the stock market during the next few weeks. Along with this, it is advisable to place bets on six those & nbsp; stocks from the firm, which can benefit the investors a lot.

Apollo Hospital

Kotak Securities, shares of Apollo Hospital have fixed a target price of Rs 8,189. The brokerage firm says that this company is witnessing better from the seventh consecutive quarters, which is a positive sign.

Ambar Enterprises

Target price of 78 hundred rupees has been fixed by Kotak Securities in Union Bank shares. The firm believes that the demand for AC room may increase in the coming days of summer, so there is a possibility in its stock. It is estimated to have a possibility of a 9% rise from its current level.

Union Bank

Union Bank shares have been given a target price of Rs 155 by Kotak Securities. That is, it is estimated to have a rise of about 23 percent. It has been said by the Kotak firm that the current valuation of this stock is attractive.

Adani ports

Adani Ports have been given a price target of Rs 1570 in the shares of Kotak Securities. That is, its stock has been estimated to be about 32 percent. The firm says that this company is moving towards an entire transport solutions provider, which will promote logistics.

Also read: Swiggy received a notice of Rs 158 crore from Income Tax Department, this is the plan of the company against it

Source link

The post 8% jump in Tata Consumer Product, which stocks will rock appeared first on .